Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear Members, The early bird registration deadline for CBS 2023 in Halifax has been extended to April 21st, 2023 To register, click here...

Dear Members, The abstract submission deadline for CBS 2023 in Halifax has been extended to March 17th, 2023 Please click here to learn more...

The Exploration of Biomat-X EBMX invites you to submit your next original contribution to the inaugural edition of this journal to help the journal positioning itself among the major players in the field...

Dear Members, Reistration for CBS 2023 at Dalhousie University in Halifax, NS is officially open You can register here...

Allergic conjunctivitis affects nearly 40 of the North American population 1 . Topical eye drops are the most common treatment method, but it is generally accepted that less than 5 of an applied dose remains bioavailable, resulting in frequent reapplication 2 , 3 ...

Bone defects, especially large ones, still present a significant challenge in orthopedic tissue engineering, due to the limited self-repair capacity of bone tissues...

Arterial bypass graft is the primary therapy for patients with advanced vascular occlusion diseases and, in recent years, the development of tissue-engineered vascular grafts has emerged as a promising, clinically applicable alternative to autografts...

Most strategies aiming at developing biocompatible arterial prostheses target the recruitment of endothelial cells EC to reproduce a native artery intima...

Tumors behavior involves complicated molecular biology and correspondingly complicated dynamics. Primary malignant tumors originate from small numbers of cells that go through an avascular devoid of blood vessels mode at their early stage of growth 1 ...